Microbot Medical Inc. Announces CEO to Speak at SRS 2026 Annual Meeting

What Happened Microbot Medical Inc. announced on July 21, 2026 (Form 8-K, Regulation FD disclosure) that Harel Gadot, the company’s CEO, President and Chairman, will participate in the Society of Robotic Surgery (SRS) annual meeting in Fort Lauderdale, FL, July 23–26, 2026. He will present an overview of the endovascular robotic market and discuss emerging technologies in peripheral vascular, neurovascular and cardiovascular spaces. The panel will be livestreamed at 10:25 am ET (link furnished in the press release). The press release is furnished as Exhibit 99.1 to the 8-K.

Key Details

• 8-K filed and press release dated July 21, 2026 (Regulation FD disclosure).
• SRS annual meeting dates: July 23–26, 2026; location: Fort Lauderdale, FL.
• Speaker: Harel Gadot — CEO, President and Chairman of Microbot Medical.
• Presentation topic: endovascular robotic market and emerging peripheral, neurovascular and cardiovascular technologies; panel livestream at 10:25 am ET.

Why It Matters This disclosure gives investors notice that Microbot’s CEO will publicly discuss the company’s market area and technologies at a major industry conference, increasing visibility among clinicians, partners and investors. Because the item is a Regulation FD filing, it ensures the information was released publicly and not as selective disclosure. The filing does not report financial results, executive changes, or other material corporate actions.